Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant-Reference-Cited by-同舟云学术

Retrospective evaluation of fidaxomicin versus oral vancomycin for treatment of Clostridium difficile infections in allogeneic stem cell transplant

Published:2018-12 Issue:4 Volume:11 Page:233-240
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Prohaska Laura,Mahmoudjafari Zahra,Shune Leyla,Singh Anurag,Lin Tara,Abhyankar Sunil,Ganguly Siddhartha,Grauer Dennis,McGuirk Joseph,Clough Lisa

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference26 articles.

1. Incidence and outcomes of Clostridium difficile associated disease in hematopoietic stem cell transplant recipients;Guddatti;Int J Hematol,2014

2. Centers for Disease Control. Frequently asked questions about Clostridium difficile for healthcare providers. Centers for Disease Control webpage. [Updated 6 Mar 2012]. Available from: http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_faqs_HCP.html. [Accessed 29 Aug 2016].

3. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison;Cornely;J Antimicrob Chemother,2014

4. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA);Cohen;Infect Control Hosp Epidemiol,2010

5. Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation;Callejas-Diaz;Curr Hematol Malig Rep,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bring it on again: antimicrobial stewardship in transplant infectious diseases: updates and new challenges;Antimicrobial Stewardship & Healthcare Epidemiology;2024

2. Comparative Effectiveness of Fidaxomicin vs Vancomycin in Populations With Immunocompromising Conditions for the Treatment of Clostridioides difficile Infection: A Single-Center Study;Open Forum Infectious Diseases;2023-12-08

3. Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-11

4. Real-world comparison of fidaxomicin versus vancomycin or metronidazole in the treatment of Clostridium difficile infection: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2022-09-03

5. Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes;Open Forum Infectious Diseases;2022-09-02